BPA Call 75F40124A00003-75F40124F19006

Award Date 9/16/24
Potential Completion Date 9/16/25
Potential Value $494K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Deloitte Consulting LLP, a leading management and technology consulting firm, to provide a wide range of professional services to the Food and Drug Administration (FDA). The contract, valued at $7,605,848.35, is a Blanket Purchase Agreement (BPA) Call under the Multiple Award Schedule (MAS) contract vehicle. The services to be delivered include IT modernization, data analytics, cybersecurity, program management, and organizational transformation support....
This is a $2,396,722.20 Blanket Purchase Agreement (BPA) Call contract awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, a management and technology consulting firm. The contract is for strategic portfolio management support for the FDA's Office of Digital Transformation (ODT) in Fiscal Year 2024. The contract utilizes the Multiple Award Schedule (MAS) procurement vehicle and is a labor hours pricing type. This award does not have a set-aside designation. Deloitte...
This is a $11,263,189.85 Blanket Purchase Agreement (BPA) call awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP for budget execution and control support services. The contract has an ultimate completion date of September 28, 2027 and does not utilize a set-aside designation. Deloitte Consulting, a large management and technology consulting firm, will provide a range of services to the FDA including IT modernization, data analytics, cybersecurity, program management,...
This is a $27,707,196.82 Blanket Purchase Agreement (BPA) contract awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, doing business as Deloitte. The contract is for CDERONE CORE SUPPORT services, which likely includes IT modernization, data analytics, cybersecurity, program management, and organizational transformation support for the FDA. The contract is a BPA Call under the Multiple Award Schedule (MAS) contract vehicle, allowing for flexible task order issuance...
This is a federal contract awarded by the Department of Health and Human Services Food and Drug Administration to Deloitte Consulting LLP, a leading management and technology consulting firm. The contract is for the "CDER INFORMATICS MODERNIZATION STRATEGY AND SUPPORT FOR SUPPLY CHAIN INSIGHTS" and has a potential value of $4,001,094.38. The contract does not have a set-aside designation and is a Blanket Purchase Agreement (BPA) Call under the Multiple Award Schedule (MAS) contract...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, doing business as Deloitte, for drug labeling services. The contract has a ceiling value of $1,520,196.84 and a period of performance ending on March 31, 2025. The contract was not set aside for any socioeconomic program. Deloitte is a leading management and technology consulting firm that provides a wide range of services to federal agencies,...
This is a $1,647,673.96 federal contract awarded by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, doing business as Deloitte, for Janus Independent Verification and Validation (IV&V), Testing, and Operational Support. The contract is a Blanket Purchase Agreement (BPA) call order issued under the FDA Data and Analytics BPA, which has a potential ceiling value of $500 million. This contract does not have a set-aside designation. Deloitte, a leading global management and...
This is a Blanket Purchase Agreement (BPA) task order awarded by the Food and Drug Administration (FDA) to Deloitte & Touche LLP, a prominent professional services firm, to support the agency's FY 2021 internal controls assessments under the A-123 program. The $11,595,670.91 firm-fixed price contract has a period of performance through July 2026 and is not set aside for any specific business type. Deloitte, as the prime contractor, will be responsible for maturing the FDA's internal controls...
The U.S. Food and Drug Administration (FDA) awarded a Blanket Purchase Agreement (BPA) Call task order to Deloitte Consulting LLP, doing business as Deloitte, for an OCS JANUS Non-Clinical Study Data Platform (SDP). The $1,353,349.52 task order was issued under Deloitte's existing $99 million FDA BPA for drug supply chain management services. This contract is not set aside for any preference program. Deloitte, a leading management and technology consulting firm, has extensive experience...
This federal contract award under HHSF223201310013B was issued by the Food and Drug Administration (FDA) to Deloitte Consulting LLP, a large management and technology consulting firm. The $4,059,121.57 contract is a Blanket Purchase Agreement (BPA) call under the FDA's BPA for Integrity Services Phase XVII, utilizing the Information Technology Schedule 70 contract vehicle. The contract provides labor hours for integrity call services, with no set-aside designation. Deloitte, the prime...

This is a federal contract award to Deloitte Consulting LLP, a leading global management and technology consulting firm, to provide programmatic implementation assessment services to the Food and Drug Administration (FDA) for the Drug Supply Chain Security Act (DSCSA) Operational Compliance (OC) program. The contract is a Blanket Purchase Agreement (BPA) call under the Multiple Award Schedule (MAS) contract vehicle, with a ceiling value of $494,448.50 and a performance period ending on September 16, 2025. The contract does not have a set-aside designation. As a prime contractor, Deloitte will be responsible for delivering a range of services, including IT modernization, data analytics, and program management support, to assist the FDA in its DSCSA OC program implementation. This contract award is part of Deloitte's broader portfolio of federal contracts and task orders, which includes several large Indefinite Delivery/Indefinite Quantity (IDIQ) vehicles with various government agencies.

Generated 4/2/25, 9:56 AM